Literature DB >> 10621807

BAL fluid cytology in the assessment of infectious lung disease.

J A Jacobs1, E De Brauwer.   

Abstract

The need for rapid laboratory results has marked the application of bronchoalveolar lavage (BAL) fluid cytology as a valuable tool in the assessment of infectious lung conditions. The techniques of BAL fluid processing presented here can be performed in a microbiological laboratory. The diagnostic value of BAL fluid cytology for the prediction of ventilator-associated pneumonia is discussed.

Entities:  

Mesh：

Year:  1999        PMID： 10621807     DOI： 10.12968/hosp.1999.60.8.1172

Source DB:  PubMed          Journal:  Hosp Med        ISSN： 1462-3935


  5 in total

1.  Accuracy and precision of quantitative calibrated loops in transfer of bronchoalveolar lavage fluid.

Authors:  J A Jacobs; E I De Brauwer; E I Cornelissen; M Drent
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Detection of Streptococcus pneumoniae antigen in bronchoalveolar lavage fluid samples by a rapid immunochromatographic membrane assay.

Authors:  Jan A Jacobs; Ellen E Stobberingh; Elisa I M Cornelissen; Marjolein Drent
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?

Authors:  Petal A Wijnen; Johny A Verschakelen; Aalt Bast; Otto Bekers; Marjolein Drent
Journal:  Lung       Date:  2012-11-13       Impact factor: 2.584

4.  Influence of antibiotic therapy on the cytological diagnosis of ventilator-associated pneumonia.

Authors:  Catharina F M Linssen; Jan A Jacobs; Jan S A G Schouten; Walther N K A van Mook; Graham Ramsay; Marjolein Drent
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

5.  Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?

Authors:  Marijke J Vanspauwen; Catharina F M Linssen; Cathrien A Bruggeman; Jan A Jacobs; Marjolein Drent; Dennis C J J Bergmans; Walther N K A van Mook
Journal:  Crit Care       Date:  2011-01-11       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.